Johnsons&Johnson

COVID-19 Vaccine BY Johnson & Johnson Showed 66 % Effective In Phase 3 Of Global Trial

Johnson & Johnson is going to file for emergency use authorisation from the US Food and Drug Administration in a week.  This will be the third company to seek EUA from the FDA for a coronavirus vaccine.